According to The American Diabetes Association there are over 25 million people in the US living with diabetes. These patients are suffering from complications such as heart disease, stroke, high blood pressure, blindness, kidney disease, neuropathy and amputation. Since adult stem cells have the ability to differentiate into many different types of cells, such as those required for proper pancreatic functioning, StemGenex® believes there is hope for these patients.
StemGenex® is currently studying ways to regenerate insulin producing cells within the pancreas by using adult stem cells. By harvesting adipose derived stem cells through a mini-liposuction procedure, the doctors can then minimally manipulate the stem cells in an on-site lab before reintroducing them back into the patient's body, the very same day. Once the stem cells are reintroduced, StemGenex believes they may differentiate into insulin producing cells of the pancreas. StemGenex is studying outcomes such as better glycemic control, decreases in insulin requirement, as well as reductions in HBA1C and triglyceride levels.